Association of Tumor Stage and Molecular Subtype With Three-Year Recurrence Outcomes After Adjuvant Radiotherapy in Stage I-III Breast Cancer: A Single-Centre 2022 Cohort Study
Cureus · 12.05.2026
DOI: 10.7759/cureus.108710 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Cureus, erschienen am 12.05.2026. Verfasst von Nusrat Nazar und 5 weiteren Autor:innen. Beteiligte Einrichtung: Oncology, Cancer Care Hospital & Research Centre, Lahore, PAK. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Oncology, Cancer Care Hospital & Research Centre, Lahore, PAK.
Zitieren
APA
Nazar, N., Ghumman, A. R., Waqar, A. S., Sahi, M. A., Ilyas, A., & Haider, N. (2026). Association of Tumor Stage and Molecular Subtype With Three-Year Recurrence Outcomes After Adjuvant Radiotherapy in Stage I-III Breast Cancer: A Single-Centre 2022 Cohort Study. Cureus. https://doi.org/10.7759/cureus.108710
Vancouver
Nazar N, Ghumman AR, Waqar AS, Sahi MA, Ilyas A, Haider N. Association of Tumor Stage and Molecular Subtype With Three-Year Recurrence Outcomes After Adjuvant Radiotherapy in Stage I-III Breast Cancer: A Single-Centre 2022 Cohort Study. Cureus. 2026. doi:10.7759/cureus.108710
BibTeX
@article{Nazar2026,
author = {Nazar, Nusrat and Ghumman, Ahmad R and Waqar, Abdul S and Sahi, Mohammad A and Ilyas, Aleesha and Haider, Naeem},
title = {Association of Tumor Stage and Molecular Subtype With Three-Year Recurrence Outcomes After Adjuvant Radiotherapy in Stage I-III Breast Cancer: A Single-Centre 2022 Cohort Study},
journal = {Cureus},
year = {2026},
doi = {10.7759/cureus.108710}
}
EUVIMED